We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Epithelial Cells Produce C-Reactive Protein

By Biotechdaily staff writers
Posted on 05 Apr 2005
Researchers studying the molecular basis for cardiovascular disease have found that the epithelial cells that line the arteries produce C-reactive protein (CRP), which has been linked to inflammatory processes.

Investigators at the University of California, Davis (USA), working with human aortic endothelial cells (HAEC) examined the effect of vascular smooth muscle cell (VSMC) and/or macrophage-conditioned media (MCM) on the growth of HAEC in culture. More...
They used reverse transcription-polymerase chain reaction (RT-PCR) to detect the presence of CRP messenger RNA (mRNA) in HAEC, and they measured intracellular protein by Western blot and secreted protein by an enzyme-linked immunosorbent assay (ELISA).


Results published in the April 2005 issue of the American Journal of Pathology revealed that endothelial cells produced C-reactive protein. CRP production was stimulated by interleukin-1 and interleukin-6. While VSMC-conditioned media had no effect, incubation with MCM resulted in a significant twofold increase in the synthesis of both intracellular and secreted CRP. Inhibiting both interleukin-1 and interleukin-6 could reverse the effect of MCM.

"This is an extremely important finding,” said senior author Dr. Ishwarlal Jialal, professor of pathology and internal medicine at the University of California, Davis. "We have convincingly demonstrated in this paper that aortic and coronary artery endothelial cells produce and secrete C-reactive protein. The C-reactive protein produced by endothelial cells cannot only act on the endothelial cells, but also on macrophages and smooth muscle cells in the atheroma. This creates a vicious cycle, leading to plaque instability and rupture, and ultimately heart attacks and strokes.”

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Automatic CLIA Analyzer
Shine i6000
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.